Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cardio-protective Effect of Metformin in Elective PCI
NCT05708053Phase 3Completed
- Sponsor
- Future University in Egypt
- Start
- Dec 2019
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of liquid metformin (Aspargo Labs) in ischemia-reperfusion injury (IRI), sponsored by Future University in Egypt. Started Dec 2019; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
ischemia-reperfusion injury (IRI)
Beyond the preview
Go deeper on NCT05708053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05708053.